Plasmapheresis-refractory thrombotic microangiopathy in a hematopoietic stem cell transplant recipient

Ther Apher Dial. 2011 Oct;15(5):507-9. doi: 10.1111/j.1744-9987.2011.00978.x.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Antibodies, Monoclonal, Murine-Derived / therapeutic use*
  • Combined Modality Therapy
  • Female
  • Graft vs Host Disease / drug therapy
  • Hematopoietic Stem Cell Transplantation / adverse effects*
  • Humans
  • Immunosuppressive Agents / therapeutic use
  • Middle Aged
  • Plasmapheresis / methods*
  • Precursor Cell Lymphoblastic Leukemia-Lymphoma / therapy
  • Rituximab
  • Thrombotic Microangiopathies / etiology
  • Thrombotic Microangiopathies / therapy*

Substances

  • Antibodies, Monoclonal, Murine-Derived
  • Immunosuppressive Agents
  • Rituximab